PHG Stock Analysis: Buy, Sell, or Hold?
PHG - KONINKLIJKE PHILIPS N.V.
$28.70
-0.55 (-1.88%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 18, 2026
17d
Get Alerted When PHG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PHG shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: PHG shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$37.80
Based on 6.6% avg growth
INTRINSIC VALUE TODAY
$23.47
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PHG is currently trading at $28.70, which is considered fair relative to its 30-day fair value range of $27.63 to $29.79. The stock's valuation (Forward PE: 16.7) is in line with its historical norms (15.7). At these levels, the market is pricing in 2.1% annual earnings growth.
Technical Outlook: Technically, PHG is in a uptrend. The price is currently testing key support at $28.39. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (23th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $32.52 (+11.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PHG is in a uptrend. The price is currently testing key support at $28.39. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (23th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $32.52 (+11.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$27.63 -
$29.79
Company Quality Score
53/100
(HOLD)
Options IV Signal
23th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
78.5%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 23th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($32.52)
- BULLISH: Expecting earnings turnaround to 2.1% growth with -1.7% revenue growth
Fair Price Analysis
30-Day Fair Range
$27.63 -
$29.79
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$1.28
(4.4%)
Support & Resistance Levels
Support Level
$28.39
Resistance Level
$29.99
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
16.67
Wall Street Target
$32.52
(+11.2%)
Revenue Growth (YoY)
-1.7%
Earnings Growth (YoY)
-0.5%
Profit Margin
0.9%
Valuation Premium vs History
+2.1% premium
PE vs Historical
16.7 vs 15.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.1%
(market-implied from PE analysis)
1-Year Target
$29.86
(+2%)
2-Year Target
$30.49
(+4%)
3-Year Target
$31.13
(+6%)
3-Yr Target (if PE normalizes)
(PE: 17→16)
PE COMPRESSION
$29.32
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 9.1%)
$50.81
(+74%)
Base:
(SPY PE: 16.7, Growth: 9.1%)
$37.99
(+30%)
Bear:
(PE: 14.2, Growth: 9.1%)
$32.29
(+10%)
📈
Valuation based on Current Earnings
Forward PE: 16.21 | Forward EPS (Implied): $1.77
Bull Case
$34.66
(+21%)
Analyst growth 15.0%, PE expands to 17.0
Base Case
$28.70
(0%)
Market implied 0.0%, PE stable at 16.2
Bear Case
$21.96
(-24%)
Severe decline -15.0%, PE contracts to 14.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 31, 2026 2:47 PM ET
Data refreshes hourly during market hours. Next update: 3:47 PM
Data refreshes hourly during market hours. Next update: 3:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$374 | 54 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced PHG Option Strategies
Professional options setups generated by AI based on today's PHG price and gamma walls.
